Goal amount for this month: 30 USD, Received: 0 USD (0%)
Download Human Cell Culture Cancer Cell Lines Part 1 inside Othersforums : Human Cell Culture: Cancer Cell Lines Part 1ByBeverly A. Teicher (auth.), John R. W. Masters, Bernhard Palsson (eds.) ...
Human Cell Culture: Cancer Cell Lines Part 1ByBeverly A. Teicher (auth.), John R. W. Masters, Bernhard Palsson (eds.)
2002 | 293 Pages | ISBN: 0792351436 | PDF | 2 MB
Continuous cell lines derived from human cancers are the most widely used resource in laboratory-based cancer research. The first 3 volumes of this series on Human Cell Culture are devoted to these cancer cell lines. The chapters in these first 3 volumes have a common aim. Their purpose is to address 3 questions of fundamental importance to the relevance of human cancer cell lines as model systems of each type of cancer: 1. Do the cell lines available accurately represent the clinical presentation? 2. Do the cell lines accurately represent the histopathology of the original tumors? 3. Do the cell lines accurately represent the molecular genetics of this type of cancer? The cancer cell lines available are derived, in most cases, from the more aggressive and advanced cancers. There are few cell lines derived from low grade organ-confined cancers. This gap can be filled with conditionally immortalized human cancer cell lines. We do not know why the success rate for establishing cell lines is so low for some types of cancer and so high for others. The histopathology of the tumor of origin and the extent to which the derived cell line retains the differentiated features of that tumor are critical. The concept that a single cell line derived from a tumor at a particular site is representative of tumors at that site is na?ve and misleading.
Recommend Download Link Hight Speed | Please Say ThanksKeep Topic Live
All times are GMT +1. The time now is 03:55 AM.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology